Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

ExploreCOVID: An explorative cohort study to identify optimal CT imaging biomarkers in combination with clinical markers and PCR-RT for the diagnosis and therapy response assessment of COVID-19

Funded by the German Federal Ministry of Education and Research, the ExploreCOVID project aims to analyze patient history and clinical as well as imaging data across multiple medical centers to identify standardizable diagnostic criteria. By doing so, a comprehensive database of structured data will be established which can be used for future epidemiological insights and the risk stratification of COVID-19 patients.
 
Current evidence indicates that chest CT imaging may be a valuable tool in the diagnosis, epidemiology, and therapy response evaluation of COVID-19 patients. It offers high sensitivity, short turnaround times, and wide availability. Therefore, chest CT may complement RT-PCR tests, especially in situations of unclear clinical presentation, such as a negative RT-PCR despite strong anamnestic evidence for COVID-19. More importantly, it offers opportunities to assess disease progression directly and may be a method of choice for therapy response assessment in upcoming trials of new therapeutic agents. However, to develop it into a proper instrument, a standardized quantitative approach is required. Additionally, multicentric cooperation is essential to generate a sufficiently large database with a consistently high data quality, which is crucial for modern data mining methods.
 
All centers involved in this project are provided with access to the COVID-19 functionality within the mint Lesion™ platform. The study centers can conduct structured reads on already available thoracic CT images, extract a wide range of image-based parameters (including radiomics parameters), associate them with other clinical and anamnestic data, and then transfer the resulting structured data to the project partners to identify the parameters relevant for the diagnosis and staging of COVID-19. Despite the very high number of different data sources, this approach guarantees that uniform and homogenous criteria are applied in the data extraction.
 
The results can be immediately implemented in the mint Lesion™ reading template and distributed worldwide for use in diagnostic procedures and therapy response assessments in clinical trials.

Related Resources

Related Resources

A picture of a cancer patient on a couch, with two infusion bags in the foreground

Optimizing Clinical Trials without Compromising Patient Care: An Investigational Site’s Perspective

Attracting and retaining industry-sponsored clinical trials can be quite appealing for healthcare institutions. Besides obvious financial and…

A picture of a cancer patient talking to the doctor who is treating her.

Closing the Care Gap by Shaping the Future of Evidence-Based Medicine

Healthcare still lags behind other economic sectors in terms of digitalization. Despite significant advancements in diagnostic and therapeutic…

Three Key Benefits of Structured Reporting in Daily Clinical Routine

In this short interview, Dr. Remy Geenen from Northwest Clinics in Alkmaar, Netherlands, shares his personal mint Lesion™ experience, where he talks…